SEC Form 4 · accession 0001628280-26-047075
agilon health, inc. · AGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey A. Schwaneke
Officer — Chief Financial Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 2, 2026 · 6:44 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001831097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 1, 2026 | F | 2,311 | $111.74 | D | 138,031 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
- F2Includes restricted stock units.